2 assets in Hereditary Angioedema Type 2

Therapeutic assets addressing Hereditary Angioedema Type 2, rated under Floatz methodology v0.2 and sorted by current rating.

Asset	Sponsor	Phase	Rating
Deucrictibant Hereditary Angioedema Type 2	Pharvaris Netherlands B.V.	P3	BBB (73)
Adx-324 Hereditary Angioedema Type 2	ADARx Pharmaceuticals, Inc.	P3	B (60)